Growth hormone alleviates oxidative stress and improves the IVF outcomes of poor ovarian responders: a randomized controlled trial

被引:0
|
作者
Yan Gong
Kun Zhang
Dongsheng Xiong
Jiajing Wei
Hao Tan
Shengfang Qin
机构
[1] The Affiliated Women’s and children’s Hospital of Chengdu Medical College,Reproductive Medicine Centre, Sichuan Provincial Women’s and Children’s Hospital
[2] Chengdu Medical College,Department of Genetics, School of Bioscience and Technology
[3] The Affiliated Women’s and children’s Hospital of Chengdu Medical College,Department of Medical Genetics and Prenatal Diagnosis, Sichuan Provincial Women’s and Children’s Hospital
关键词
Poor ovarian response; In vitro fertilization; Growth hormone; Oxidative stress; Reactive oxygen species;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Testosterone does not improve ovarian response in Bologna poor responders: a randomized controlled trial (TESTOPRIM)
    Subira, Jessica
    Algaba, Anna
    Vazquez, Sheila
    Taroncher Dasi, Roser
    Molla Robles, Guillermo
    Monzo Fabuel, Susana
    Baydal, Virginia
    Ruiz Herreros, Amparo
    Garcia Camunas, Nuria
    Rubio Rubio, Jose Maria
    REPRODUCTIVE BIOMEDICINE ONLINE, 2021, 43 (03) : 466 - 474
  • [32] Empirical use of growth hormone in IVF is useless: the largest randomized controlled trial
    Mourad, Ali
    Jamal, Wael
    Hemmings, Robert
    Tadevosyan, Artak
    Phillips, Simon
    Kadoch, Isaac-Jacques
    HUMAN REPRODUCTION, 2024,
  • [33] Are AMH level and AFC useful predictors of outcomes in poor ovarian responders? A post hoc analysis of the ESPART randomized controlled trial
    Chin, W.
    Hubbard, J.
    Humaidan, P.
    HUMAN REPRODUCTION, 2016, 31 : 16 - 16
  • [34] 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial
    Lefebvre, Jessica
    Antaki, Roland
    Kadoch, Isaac-Jacques
    Dean, Nicola L.
    Sylvestre, Camille
    Bissonnette, Francois
    Benoit, Joanne
    Menard, Sylvain
    Lapensee, Louise
    FERTILITY AND STERILITY, 2015, 104 (06) : 1419 - 1425
  • [35] Growth hormone co-treatment in IVF/ICSI cycles in poor responders
    Ob'edkova, Ksenia
    Kogan, Igor
    Krikheli, Inna
    Dzhemlikhanova, Lyailya
    Muller, Valeria
    Mekina, Irina
    Lesik, Elena
    Komarova, Evgenia
    Mazilina, Maria
    Niauri, Dariko
    Gzgzyan, Alexandr
    Aylamazyan, Edward
    GYNECOLOGICAL ENDOCRINOLOGY, 2017, 33 : 15 - 17
  • [36] Six-week pretreatment with growth hormone improves clinical outcomes of poor ovarian responders undergoing in vitro fertilization treatment: A self-controlled clinical study
    Cai, Mei-Hong
    Liang, Xiao-Yan
    Wu, Yao-Qiu
    Huang, Rui
    Yang, Xing
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2019, 45 (02) : 376 - 381
  • [37] GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial
    Cheung, LP
    Lam, PM
    Lok, IH
    Chiu, TTY
    Yeung, SY
    Tjer, CC
    Haines, CJ
    HUMAN REPRODUCTION, 2005, 20 (03) : 616 - 621
  • [38] ADJUVANT GROWTH HORMONE USE IMPROVES EUPLOID RATE IN WOMEN UNDERGOING IVF/PGT-A WHO ARE NOT POOR RESPONDERS
    Leonard, Whitney A.
    Mak, Winifred
    Skillern, Amanda
    Pike, Jordyn
    FERTILITY AND STERILITY, 2019, 112 (03) : E135 - E135
  • [39] Human growth hormone for poor responders: a randomized placebo-controlled trial provides no evidence for improved live birth rate
    Norman, Robert J.
    Alvino, Helen
    Hull, Louise M.
    Mol, Ben W.
    Hart, Roger J.
    Kelly, Thu-Lan
    Rombauts, Luk
    Henshaw, Richard
    Bowman, Mark
    Smith, Howard
    Illingworth, Peter
    Ledger, William
    Hales, Lyndon
    Birdsall, Mary
    Yovich, John
    REPRODUCTIVE BIOMEDICINE ONLINE, 2019, 38 (06) : 908 - 915
  • [40] FOLLICULAR FLUSHING IN VERY POOR RESPONDERS: A RANDOMIZED CONTROLLED TRIAL
    Mok-Lin, E.
    Aelion-Brauer, A.
    Spandorfer, S.
    Rosenwaks, Z.
    FERTILITY AND STERILITY, 2012, 98 (03) : S57 - S57